MB-6

DRUG2 trials

Sponsors

Microbio Co Ltd

Conditions

Colorectal CancerNeutropeniaStage III Colorectal Cancer

Phase 2

A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)

CompletedNCT01047475

Microbio Co LtdColorectal Cancer

Start: 2009-10-31End: 2011-12-31Updated: 2015-05-13

Unknown Phase

A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.

Microbio Co LtdNeutropenia, Stage III Colorectal Cancer

Start: 2013-11-04End: 2022-12-31Target: 184Updated: 2020-12-22